Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1378-1383

  Arneson, Thomas J ^a   Zaun, David ^a   Peng, Yi ^a   Solid, Craig A ^a   Dunning, Stephan ^a   Gilbertson, David T ^a  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Dialysis; Haemoglobin levels; Haemoglobin variability

Indexed keywords

HEMOGLOBIN;

ANEMIA; COHORT ANALYSIS; DATA ANALYSIS; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MEDICAL ABORTION; PRIORITY JOURNAL; REVIEW; UNITED STATES; VARIANCE;

ANEMIA; HEMATOCRIT; HEMOGLOBINS; HUMANS; KIDNEY FAILURE; MEDICARE; RENAL DIALYSIS; UNITED STATES;

EID: 65249183843     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp018     Document Type: Review

References (19)

1. U.S. Renal Data System. USRDS 2007 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disorders, Bethesda, MD, 2007
2. KDOQI. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47: S11-S145
3. Besarab A, Bolton JK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
4. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
5. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
6. Ebben JP, Gilbertson DT, Foley RN et al. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospital-izations. Clin J Am Soc Nephrol 2006; 1: 1205-1210
7. Fishbane S, Berns JS. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 2005; 68: 1337-1343
8. Lacson E Jr, Ofsthun N, Lazarus JM. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 2003; 41: 111-124
9. Brunelli SM, Joffe MM, Israni RK et al. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 777-782
10. Yang W, Israni RK, Brunelli SM et al. Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 2007; 18: 3164-3170
11. Berns JS, Elzein H, Lynn RI et al. Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int 2003; 64: 1514-1521
12. Collins AJ, Brenner RM, Ofman JJ et al. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. Am J Kidney Dis 2005; 46: 481-488
13. Centers for Medicare and Medicaid Services. 2006 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standard & Quality. Available at www.cms.hhs.gov/. Accessed 6 November 2008
14. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from12countries inthe Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
15. Sulowicz W, Locatelli F, Ryckelynck JP et al. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol 2007; 2: 637-646
16. West RM, Harris K, Gilthorpe MS et al. Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemia. J Am Soc Nephrol 2007; 18: 2371-2376
17. Gilbertson DT, Ebben JP, Foley RN et al. Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol 2008; 3: 133-138
18. U.S. Renal Data System. USRDS 2006 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006
19. Feldman HI, Brunelli SM, Joffe MM et al. Causal analysis of hemoglobin variability and mortality among hemodialysis patients [Abstract]. J Am Soc Nephrol 2006; 17: 583A